Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

NCT01047995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Raltegravir plus Darunavir/ritonavir
DRUG: Raltegravir plus Darunavir/ritonavir

Sponsor

St Stephens Aids Trust